J. D. Yang

Hepatology · 2010–2022

A researcher in the Science corpus: 9 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom J. D. Yang trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. H. B. EL‐SERAG
  2. J. Llovet
  3. C. Lo
  4. F. Bray
  5. K. Rudolph
  6. Cynthia L Ogden
  7. K. Flegal
  8. J. Ferlay
  9. Alejandro Forner1 , 2
  10. Jordi Bruix1 , 2

Who trusts J. D. Yang overall

  1. Lewis R. Roberts

Papers from J. D. Yang's perspective

Ordered by how strongly the researchers J. D. Yang trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. (The Lancet Oncology)
  2. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. (Gastroenterology)
  3. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. (The Lancet)
  4. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. (American Journal of Epidemiology)
  5. Randomized controlled trial of screening for hepatocellular carcinoma (Journal of Cancer Research and Clinical Oncology)
  6. Primary liver cancer: worldwide incidence and trends. (Gastroenterology)
  7. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? (Hepatology)
  8. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. (Journal of Hepatology)
  9. Prevalence of overweight and obesity in the United States, 1999-2004. (Journal of the American Medical Association (JAMA))
  10. A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma (Annals of Surgery)

Their papers